Patrick Muller

Statistician and epidemiologist, formerly of @LSHTM now at @NICEComms

[Sotirios (Sotos) Tsaftaris @STsaftaris]

Delighted to lead the #CHAIhub with @GlockerBen (@imperialcollege), @HanaChockler (@KingsCollegeLon), @MattSperrin (@UniversityManch ), @SabinaLeonelli (@UniofExeter), Ricardo Silva (@ucl). We will bring together #academia and #industry for #causal #AI for #health real data 1/2

[greg @greg16676935420]

AI vs Blueberry, a thread:

[MARCH Centre, LSHTM @MARCH_LSHTM]

Risk of premature birth up to 50% higher in mothers with poor mental health according to 🆕 research in @TheLancetPsych 🧠

✍️ @ipeet @PatrickM42 @JanvanderMeule6 & colleagues @KingsCollegeLon @RCObsGyn @StGeorgesUni @dmuleicester @LivUni @Sydney_Uni

👉 https://t.co/NcrG6CproT

[PLOS Medicine @PLOSMedicine]

Patrick Muller, Amar M Karia & colleagues investigate adverse outcomes in women with low-risk pregnancies undergoing induction of labour at 39 weeks, according to ethnicity, socioeconomic deprivation and parity: https://t.co/Iqm5soyeJz
@PatrickM42 @NeonatalNurstin @ipeet

[Dr. Glaucomflecken @DGlaucomflecken]

It’s not about the money

[PLOS Medicine @PLOSMedicine]

Ipek Gurol-Urganci & colleagues study obstetric intervention rates and pregnancy outcomes in England during the first year of the COVID-19 pandemic:
https://t.co/a3wDtTuy59
@profasmakhalil @RCObsGyn @NMPA_audit @CRRDMU @PatrickM42 @ipeet @jenejardine
#pregnancy #COVID

[London School of Hygiene & Tropical Medicine @LSHTM]

#COVID19 dogs could revolutionise how we detect the virus.

But these clever canines need your help getting odour samples 🐕‍🦺

If you've taken a positive #PCR test in the past 3⃣ days, find out how you can volunteer 👉 https://t.co/XcGCjn1QaJ

@MedDetectDogs @durham_uni

[NMPA @nmpa_audit]

Published today our sprint audit on Ethnic and Socio-economic Inequalities in Maternity and Perinatal Care. Read the report here:
https://t.co/N9Lme8IdlN
@RCObsGyn @HQIP @LSHTM @MidwivesRCM @RCPCHtweets

[Ipek Gurol Urganci @ipeet]

Stark racial and social inequalities in pregnancy outcomes in over a million births | LSHTM https://t.co/j7SFR45EyQ @jenejardine @PatrickM42 @JanvanderMeule6 @ProfAsmaKhalil @NeonatalNurstin

[Jen Jardine @jenejardine]

New paper in @TheLancet using @nmpa_audit data estimates the proportion of adverse birth outcomes (stillbirth, preterm birth, and fetal growth restriction) in England that are attributable to socioeconomic & ethnic inequality. Read here: https://t.co/zfboBEjf25 @RCObsGyn @LSHTM

[Patrick Muller @PatrickM42]

Now available fully open access in AJOG: our cohort study on how 10-year reoperation risk varies between women who had different initial surgical treatments for stress urinary incontinence. https://t.co/v44Zrf8PiL

[Michael Ehrenstein @MikeEhrenstein]

Its taken 8 years to publication today! Thanks to the colleagues, funders and patients who made this possible. 3fold fewer #lupus flares with belimumab after Rituximab @VersusArthritis⁩ ⁦@UCLHresearch⁩ ⁦@GSK⁩ ⁦@ucl⁩ ⁦@LUPUSUK⁩ https://t.co/hMCMHTSeah

[Muge Cevik @mugecevik]

There are several reasons to think that the new UK #SARSCoV2 variant is an important one as it might be more contagious than other variants, but there are also some uncertainties. So much misinformation is being circulated, so this thread brings key data together. 🧵

[Patrick Muller @PatrickM42]

@stats_q Mail-in voting and COVID would be my guess, which I suppose comes under sampling issues. In both UK and USA polls have been inaccurate for a while though, I wonder if they're still struggling to interpret internet polls mixed up with phone polls.

[Patrick Muller @PatrickM42]

The BEAT-LUPUS trial analysis plan is now published! Will evaluate anti-dsDNA and flares, and whether effect of belimumab is mediated through steroid dose changes. Results later in 2020. @MikeEhrenstein @CarolinendLupus @UCL_CCTU @VersusArthritis

https://t.co/ELhetjuHmz

[Patrick Muller @PatrickM42]

@guardianworld Were small sample sizes and random variability considered when examining these mortality rates? If not it could explain much of this. A trust seeing 10 patients could have 80% mortality, but really that's compatible with underlying mortality as low as 44% (or high as 97%!).

[UCL Comprehensive Clinical Trials Unit @UCL_CCTU]

SAP published for the KERALINK trial, testing the hypothesis that corneal cross-linking (CXL) treatment reduces the progression of keratoconus in comparison to standard care in patients aged 10–16 years. Results expected later this year!

#keratoconus

https://t.co/PF3OeqljkV

[Inequalities in Cancer Outcomes Network @icon_lshtm]

Published this week in Cancer Epidemiology 'Temporal and geographic changes in stage at diagnosis in England during 2008–2013: A population-based study of colorectal, lung and ovarian cancers'. Research by @icon_lshtm's @PatrickM42 Check it out here!: https://t.co/XOe8X2tOLi

[Suzie Cro @Suzie_cro]

Great to see the statistical analysis plan for the @TARVA_Trial published! #transparency Looking forward to seeing the results! Total ankle replacement vs arthrodesis for end-stage ankle osteoarthritis 🦶 @PatrickM42 @ssskene https://t.co/jbXz6fTxNN